Hepatitis B vaccine (recombinant, Merck & Co.)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis B vaccine (recombinant, Merck & Co.)
Drug Alias Name重组乙型肝炎病毒疫苗（默克ji）Recombivax HB
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis BVirus DiseasesPoliomyelitis +[6] 
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1986/07/23
Country/TerritoryBelgiumCanadaUnited States +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovosanis NvSanofi PasteurUniversity Of Maryland, Baltimore +[4] 
Active IndicationsHepatitis B
Inactive IndicationsVirus DiseasesPoliomyelitisTetanus +[5] 

Other Information

ATC CodeJ07BC01
Related LinksN/A